Table 1.
Demographic and clinical parameters of patients with Parkinson’s disease
| Patient | Age | DD | H + Y | UPDRS IIION | UPDRS IIIOFF | PANDA | BDI-II | Medication | LEDD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 59 | 4 | 2 | 17 | 21 | 30 | 6 | Pra, Ras, Ama | 715 |
| 2 | 73 | 4 | 2 | 6 | 8 | 28 | 8 | LD, Pra | 782 |
| 3 | 65 | 1 | 2 | 4 | 5 | 30 | 1 | Pra, Ras | 152 |
| 4 | 66 | 6 | 2 | 21 | 34 | 29 | 8 | LD, Ent, Rot, Ama | 1092 |
| 5 | 72 | 5 | 2.5 | 21 | 29 | 25 | 15 | LD, Pra, Ama | 610 |
| 6 | 62 | 5 | 2 | 6 | 12 | 29 | 8 | Rop, Ras | 340 |
| 7 | 72 | 4 | 2 | 8 | 11 | 26 | 4 | Pra, Ras | 310 |
| 8 | 70 | 10 | 3 | 14 | 24 | 30 | 18 | Pra, Ras | 310 |
| 9 | 53 | 9 | 2.5 | 8 | 34 | 24 | 14 | LD, Pra, Ama | 1312 |
| 10 | 50 | 7 | 2 | 27 | 31 | 26 | 10 | Rot, Pra, Ras | 212 |
| 11 | 66 | 2 | 3 | 20 | 28 | 21 | 1 | LD, Ras, Ama | 700 |
| 12 | 66 | 9 | 2.5 | 19 | 31 | 21 | 2 | Pra, Sel | 260 |
For all patients age, disease duration (DD; in years), Hoehn and Yahr stages in the OFF state (H + Y), scores of UPDRS III under dopaminergic medication (UPDRS IIION), UPDRS after medication withdrawal (UPDRS IIIOFF), PANDA, Beck’s Depression Inventory II (BDI-II), medication (Ama = Amantadine; Ent = Entacapone; LD = Levodopa; Pra = Pramipexole; Pir = Piribedil; Ras = Rasagiline; RoP = Ropinirole; Rot = Rotigotine; Sel = Selegiline); and levodopa equivalent daily dose (LEDD; in mg) at the time of examination are listed.